Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Summary :Toxoplasma gondii has been described as a parasite with a low genetic diversity and a clonal population structure. The three main clonal lineages designated as type I, II or III largely predominate in Europe and North America. But strains not related to these main lineages circulate, notably, in other continents. They possess a shuffled combination of alleles that typify the three clonal types and unique polymorphisms detected by multilocus analysis. The population structure of Toxoplasma in these continents is also characterized by a higher genetic diversity associated with a lower linkage desequilibrium suggesting a role for genetic exchange. Due to their genomic diversity, it is difficult to draw global conclusions about their virulence. However, most of them are virulent in mice at isolation. Several reports also suggest a higher pathogenicity in humans and an association with ocular toxoplasmosis or severe cases of acquired toxoplasmosis in immunocompetent patients. T he three main types respond to the criteria for a clonal population structure of Toxoplasma (isolation of identical multilocus genotypes over large geographic areas and at interval of several years, and a strong linkage disequilibrium) (Tibayrenc et al., 1991). This simple clonal structure is accompanied by a low genetic divergence between the three main lineages (only ≈ 2 % divergence at the DNA sequence level between lineages). A large majority (84 %) of the of the single nucleotide polymorphisms (SNPs) identified among the three types are type I and II SNPs, type III polymorphisms (only 16 %) being located mainly on chromosome IV (Boyle et al., 2006). The assymetrical distribution of SNPs on chromosomes indicates that types I and III are second and first generation offspring, respectively, of a cross between a type II strain and one of two ancestral strains. The limited genetic diversity within each of these lineages and the low divergence between lineages strongly suggest that these three clonal lineages have expanded as the dominant strains relatively recently, from a common ancestor 10,000 years ago (Su et al., 2003).
Summary :Toxoplasma gondii has been described as a parasite with a low genetic diversity and a clonal population structure. The three main clonal lineages designated as type I, II or III largely predominate in Europe and North America. But strains not related to these main lineages circulate, notably, in other continents. They possess a shuffled combination of alleles that typify the three clonal types and unique polymorphisms detected by multilocus analysis. The population structure of Toxoplasma in these continents is also characterized by a higher genetic diversity associated with a lower linkage desequilibrium suggesting a role for genetic exchange. Due to their genomic diversity, it is difficult to draw global conclusions about their virulence. However, most of them are virulent in mice at isolation. Several reports also suggest a higher pathogenicity in humans and an association with ocular toxoplasmosis or severe cases of acquired toxoplasmosis in immunocompetent patients. T he three main types respond to the criteria for a clonal population structure of Toxoplasma (isolation of identical multilocus genotypes over large geographic areas and at interval of several years, and a strong linkage disequilibrium) (Tibayrenc et al., 1991). This simple clonal structure is accompanied by a low genetic divergence between the three main lineages (only ≈ 2 % divergence at the DNA sequence level between lineages). A large majority (84 %) of the of the single nucleotide polymorphisms (SNPs) identified among the three types are type I and II SNPs, type III polymorphisms (only 16 %) being located mainly on chromosome IV (Boyle et al., 2006). The assymetrical distribution of SNPs on chromosomes indicates that types I and III are second and first generation offspring, respectively, of a cross between a type II strain and one of two ancestral strains. The limited genetic diversity within each of these lineages and the low divergence between lineages strongly suggest that these three clonal lineages have expanded as the dominant strains relatively recently, from a common ancestor 10,000 years ago (Su et al., 2003).
Background Toxoplasma gondii is a widespread zoonotic protozoan parasite capable of infecting all warm‐blooded animals. Although the genotypes of T. gondii in pigs have been reported worldwide, there is no information on the genotypes and diversity of T. gondii in pigs in Grenada, West Indies. Objectives The aims of the present study were to isolate, genotype and determine the diversity of T. gondii genotypes in pigs. Methods We carried out a modified agglutination test (MAT) on blood from 149 pig hearts collected from a local meat market. Myocardial tissue homogenate from pigs that tested positive for T. gondii was homogenized and inoculated into mice for isolation of the parasite. We collected mouse tissues and extracted DNA for genotyping based on 11 polymerase chain reaction‐restriction fragment length polymorphism markers (SAG1, SAG2, alt. SAG2, SAG 3, BTUB, GRA6, L358, PK1, C22‐8, C 29‐2 and Apico). Results Out of the 149 pig hearts, 31 (20.8%) tested positive for T. gondii on MAT. Bioassays in mice yielded 12 isolates designated TgpgGr1 to TgpgGr12. Molecular characterisation of T. gondii revealed four genotypes as follows: ToxoDB #2‐clonal type III (seven isolates); ToxoDB #7 (three isolates); ToxoDB #13 (one isolate); ToxoDB #30 (1 isolate). Overall, ToxoDB #2 was the most common (58%). Toxo database (DB) # 13, which causes interstitial pneumonia in affected mice, has also been reported. Conclusion The genetic diversity of T. gondii in pigs in Grenada is lower than that in other surrounding Caribbean areas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.